An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

LLY has delivered impressive returns of 15% year-to-date, outperforming the S&P 500’s 5% decline during the same period. This ...

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

Haleon on Thursday raised its medium-term target for profit growth from 2026, banking on strength in key markets and costs ...

Homelessness, drug abuse and dirt bike riders causing havoc are some of the key concerns Northland business leaders raised ...

Trump-era crackdowns are forcing gangs like Tren de Aragua to flee the U.S. through the Northern border and exploit Canada’s ...

Look out for the key nutrients. When in doubt, try to prioritize foods with fiber and complex carbs, protein, and healthy ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

Icon's balance sheet is sound, with its revenue cyclicality and operating leverage each possessing a medium rating. Icon has historically maintained a fairly conservative balance sheet, and it ended ...

Scientists found a compound that appears to counter common mutations behind POLG-related diseases, rare conditions that harm ...